Open Clinical Trials:
CLINICAL TRIAL 19732
Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Everolimus (Cabinet)
Disease Site: Neuroendocrine, Other Endocrine System
View Trial DetailsCLINICAL TRIAL 19943
Somatostatin receptor expression in poorly-differentiated neuroendocrine carcinomas of the GI tract: analysis using 68Ga-dotatate PET scan
Disease Site: Pancreas, Gastrointestinal, Neuroendocrine, Other Endocrine System, Unknown Sites
View Trial Details